Related references
Note: Only part of the references are listed.Targeted exosomes for co-delivery of siFGL1 and siTGF-β1 trigger combined cancer immunotherapy by remodeling immunosuppressive tumor microenvironment
Xing Pei et al.
CHEMICAL ENGINEERING JOURNAL (2021)
Patient-reported outcomes of the relative severity of side effects from cancer radiotherapy
Patrick A. Williams et al.
SUPPORTIVE CARE IN CANCER (2020)
Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy
Afshin Derakhshani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Galactose-modified enzymatic synthesis of poly(amino-co-ester) micelles for co-delivery miR122 and sorafenib to inhibit hepatocellular carcinoma development
Jianhua Xie et al.
CHINESE CHEMICAL LETTERS (2020)
Clinical applications of nanomedicine in cancer therapy
Mohammad Norouzi et al.
DRUG DISCOVERY TODAY (2020)
Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment
Yinlong Zhang et al.
MEDICINAL RESEARCH REVIEWS (2020)
ADCs, as Novel Revolutionary Weapons for Providing a Step Forward Targeted Therapy of Malignancies
Nooshafarin Amani et al.
CURRENT DRUG DELIVERY (2020)
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach
Yi-Hsien Cheng et al.
ACS NANO (2020)
Signaling Pathways Underlying Anthracycline Cardiotoxicity
Valentina Sala et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML) with Prior Hypomethylating Agent (HMA) Exposure Who Achieved Remission
Tara Lin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Patient-derived xenograft models-the future of personalised cancer treatment
Jenna Bhimani et al.
BRITISH JOURNAL OF CANCER (2020)
Landscape of combination therapy trials in breast cancer brain metastasis
Jawad Fares et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models
Yuko Okamoto et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy
Zhenwei Su et al.
SMALL (2020)
Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting
Homan Kang et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Antitumor efficacy and cardiotoxic effect of doxorubicin-loaded mixed micelles in 4T1 murine breast cancer model. Comparative studies using Doxil ? and free doxorubicin
Maximiliano Cagel et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
A nano polymer conjugate for dual drugs sequential release and combined treatment of colon cancer and thrombotic complications
Mengjie Huang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
Hao Wu et al.
REDOX BIOLOGY (2020)
Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA
Jiayi Pan et al.
MOLECULAR PHARMACEUTICS (2020)
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
Laurene Fenwarth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Editorial: Emerging Therapies for Malignant Mesothelioma
Nico van Zandwijk et al.
FRONTIERS IN ONCOLOGY (2020)
Tamoxifen/raloxifene loaded liposomes for oral treatment of breast cancer
N. B. Mutlu Agardan et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Thermosensitive Chitosan-Based Injectable Hydrogel as an Efficient Anticancer Drug Carrier
Anam Ahsan et al.
ACS OMEGA (2020)
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
Kuo-Ching Mei et al.
ACS NANO (2020)
Trap and kill strategy for non-BRCA mutant pancreatic cancer by co-delivery of olaparib and JQ1 with plectin-1 targeting peptide nanoparticles
Yazhou Wang et al.
NANO TODAY (2020)
Antibody-Drug Conjugates for Cancer Therapy
Umbreen Hafeez et al.
MOLECULES (2020)
Stimulus-responsive sequential release systems for drug and gene delivery
Sepideh Ahmadi et al.
NANO TODAY (2020)
Roles of Macrophages and Exosomes in Liver Diseases
Mengyi Shen et al.
FRONTIERS IN MEDICINE (2020)
Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhancedin vivoantitumor cancer therapy in nursing care
Zhe Zhou
DRUG DELIVERY (2020)
Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms
Keith Dadson et al.
CLINICAL SCIENCE (2020)
Layer peeling co-delivery system for enhanced RNA interference-based tumor associated macrophages-specific chemoimmunotherapy
Tianqi Wang et al.
NANOSCALE (2020)
Bioprocess decision support tool for scalable manufacture of extracellular vesicles
Kelvin S. Ng et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Co-delivery of 5-fluorouracil and oxaliplatin in novel poly (3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly (lactic-co-glycolic acid) nanoparticles for colon cancer therapy
Somayeh Handali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments
Xiaomeng Wan et al.
BIOMATERIALS (2019)
A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy
Yanbing Wang et al.
BIOMATERIALS (2019)
Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer
Imran Shair Mohammad et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations
Fanfei Meng et al.
NANO LETTERS (2019)
Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment
Ying Li et al.
MOLECULAR PHARMACEUTICS (2019)
Mitochondrial Surface Engineering for Multidrug Resistance Reversal
Wei Chen et al.
NANO LETTERS (2019)
Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors
Isabelle M. S. Degors et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Prevention of paclitaxel-induced neuropathy by formulation approach
Xiaowei Zang et al.
JOURNAL OF CONTROLLED RELEASE (2019)
RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer
Erik J. van Helden et al.
MOLECULAR ONCOLOGY (2019)
Tumor safety and side effects of photobiomodulation therapy used for prevention and management of cancer treatment toxicities. A systematic review
Mariana de Pauli Paglioni et al.
ORAL ONCOLOGY (2019)
Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma
Sushant Lakkadwala et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Mathematical and computational modeling of nano-engineered drug delivery systems
Milad Shamsi et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Metformin increases cancer specific survival in colorectal cancer patients-National cohort study
Audrius Dulskas et al.
CANCER EPIDEMIOLOGY (2019)
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Lucia Salvioni et al.
CANCERS (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery
Lu Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance
Jiaqi Yu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3-or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer
Carsten-Henning Ohlmann et al.
UROLOGIA INTERNATIONALIS (2018)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Ligand-Switchable Micellar Nanocarriers for Prolonging Circulation Time and Enhancing Targeting Efficiency
Tangjian Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors
Qin Dai et al.
ACS NANO (2018)
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
Susan Tsai et al.
BMC CANCER (2018)
Reduction-sensitive mixed micelles assembled from amphiphilic prodrugs for self-codelivery of DOX and DTX with synergistic cancer therapy
Jilian Wu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Efficacy of paclitaxel/dexamethasone intra-tumoral delivery in treating orthotopic mouse breast cancer
Hen Popilski et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy
Yijia Yin et al.
MOLECULAR PHARMACEUTICS (2018)
Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 (BRCA2) Mutation
Chong Du et al.
ACS NANO (2018)
A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes
Somayeh Handali et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster et al.
BRITISH JOURNAL OF CANCER (2018)
Management of side effects during and post-treatment in breast cancer survivors
Oxana Palesh et al.
BREAST JOURNAL (2018)
Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance
Yachao Li et al.
ACS NANO (2017)
In vitro and in vivo evaluation of paclitaxel-lapatinib-loaded F127 pluronic micelles
Pouya Dehghankelishadi et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Combine and conquer: challenges for targeted therapy combinations in early phase trials
Juanita S. Lopez et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity
Songlei Zhou et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Nano-based delivery of RNAi in cancer therapy
Yong Xin et al.
MOLECULAR CANCER (2017)
Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
Huige Peng et al.
NANO LETTERS (2017)
Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers
Samira Naderinezhad et al.
RSC ADVANCES (2017)
A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)
G. Batist et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
A. Cervantes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression
Jie Qin et al.
SCIENTIFIC REPORTS (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Terrence F. Meehan et al.
CANCER RESEARCH (2017)
Pharmacokinetics and Drug Interactions Determine Optimum Combination Strategies in Computational Models of Cancer Evolution
Shaon Chakrabarti et al.
CANCER RESEARCH (2017)
Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier
Jing-jing Sun et al.
ACTA PHARMACOLOGICA SINICA (2017)
Nanoformulation-based sequential combination cancer therapy
Gayong Shim et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release
Hangxiang Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer
Jin Young Kim et al.
ANTICANCER RESEARCH (2017)
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne et al.
NATURE REVIEWS CANCER (2017)
Liposomal formulation for co-delivery of paclitaxel and lapatinib, preparation, characterization and optimization
Fatemeh Ravar et al.
JOURNAL OF LIPOSOME RESEARCH (2016)
An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic Cancer
Tianjiao Ji et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Opportunities and challenges in combination gene cancer therapy
Kent L. Nastiuk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Computational and experimental approaches for investigating nanoparticle-based drug delivery systems
M. Ramezanpour et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
Giuseppe Curigliano et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer
Christopher W. Espelin et al.
CANCER RESEARCH (2016)
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
Ryan J. O. Dowling et al.
CELL METABOLISM (2016)
Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy
Ming-Thau Sheu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Shaping Tumor Microenvironment for Improving Nanoparticle Delivery
Huile Gao
CURRENT DRUG METABOLISM (2016)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model
Masoumeh Zahmatkeshan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
Rui Xue Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation
Fatemeh Ravar et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Amrita Banerjee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy
Mudit Chowdhary et al.
ONCOTARGETS AND THERAPY (2016)
Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers
James R. Bradford et al.
ONCOTARGET (2016)
The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA
Caina Xu et al.
BIOMATERIALS SCIENCE (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Biocorona Bound Gold Nanoparticles Augment Their Hematocompatibility Irrespective of Size or Surface Charge
Abhilash Sasidharan et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
Biocorona Bound Gold Nanoparticles Augment Their Hematocompatibility Irrespective of Size or Surface Charge
Abhilash Sasidharan et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Evaluation of Extrusion Technique for Nanosizing Liposomes
Sandy Gim Ming Ong et al.
PHARMACEUTICS (2016)
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
Hiroshi Maeda
ADVANCED DRUG DELIVERY REVIEWS (2015)
Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine
Bing-Feng Zhang et al.
BIOMATERIALS (2015)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
Trastuzumab emtansine (Kadcyla®) approval in HER2-positive metastatic breast cancers
Mathilde Guerin et al.
BULLETIN DU CANCER (2015)
Computational and Experimental Advances in Drug Repositioning for Accelerated Therapeutic Stratification
Khader Shameer et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance
Chunhuan Shi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Approval may embolden industry to combine cancer therapies
Boer Deng
NATURE MEDICINE (2015)
Mouse hospital and co-clinical trial project-from bench to bedside
John G. Clohessy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Better Together: Targeted Combination Therapies in Breast Cancer
Elisa Zanardi et al.
SEMINARS IN ONCOLOGY (2015)
Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation
Abhilash Sasidharan et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
Lin Kang et al.
ACTA PHARMACEUTICA SINICA B (2015)
Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation
Pooya Dehghan Kelishady et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2015)
Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
Julie Sesen et al.
PLOS ONE (2015)
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero et al.
NATURE REVIEWS CANCER (2015)
Molecule Drugs for Enhanced Therapeutic Efficacy
Tianyue Jiang et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Micro-CT Imaging of Tumor Angiogenesis Quantitative Measures Describing Micromorphology and Vascularization
Josef Ehling et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment
Karthik Venkatakrishnan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Patient-Derived Xenografts for Individualized Care in Advanced Sarcoma
Justin Stebbing et al.
CANCER (2014)
Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation
Ebrahim Saadat et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Polyaspartic Acid Functionalized Gold Nanoparticles for Tumor Targeted Doxorubicin Delivery
Sameera V. Khandekar et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Inorganic Nanoparticle-Based Drug Codelivery Nanosystems To Overcome the Multidrug Resistance of Cancer Cells
Yu Chen et al.
MOLECULAR PHARMACEUTICS (2014)
pH-Responsive supramolecular hydrogels for codelivery of hydrophobic and hydrophilic anticancer drugs
Jing Yu et al.
RSC ADVANCES (2014)
Cancer nanomedicines: So many papers and so few drugs!
Vincent J. Venditto et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
Jeffrey A. Silverman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Solubility enhancement of paclitaxel using a linear-dendritic block copolymer
Zhengyuan Zhou et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Nanocarriers for intravenous injection-The long hard road to the market
Matthias Wacker
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Cancer stromal targeting (CAST) therapy
Yasuhiro Matsumura
ADVANCED DRUG DELIVERY REVIEWS (2012)
The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs
Ashlynn L. Z. Lee et al.
BIOMATERIALS (2012)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Twan Lammers et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients
Neil L. Berinstein et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Jose Baselga et al.
LANCET (2012)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery
Loan Huynh et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Catherine C. Smith et al.
NATURE (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Joseph G. Reynolds et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Martin Lundqvist et al.
ACS NANO (2011)
Fluorescent Nanorods and Nanospheres for Real-Time In Vivo Probing of Nanoparticle Shape-Dependent Tumor Penetration
Vikash P. Chauhan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages
Arnida et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Eric J. Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
Klaus Maier-Hauff et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Nanomaterial cell interactions: are current in vitro tests reliable?
Cordula Hirsch et al.
NANOMEDICINE (2011)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
Combination Therapy Targeting Both Tumor-Initiating and Differentiated Cell Populations in Prostate Carcinoma
Anna Dubrovska et al.
CLINICAL CANCER RESEARCH (2010)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Deposition and biokinetics of inhaled nanoparticles
Marianne Geiser et al.
PARTICLE AND FIBRE TOXICOLOGY (2010)
Nanoparticle-assisted combination therapies for effective cancer treatment
Che-Ming Jack Hu et al.
THERAPEUTIC DELIVERY (2010)
Stabilized polymeric micelles by electrostatic interactions for drug delivery system
Eui-Joon Cha et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
Fatima Cardoso et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Delayed Seizure Associated with Paclitaxel-Cremophor EL in a Patient with Early-Stage Breast Cancer
Tracey L. O'Connor et al.
PHARMACOTHERAPY (2009)
The effects of surgery on tumor growth: a century of investigations
R. Demicheli et al.
ANNALS OF ONCOLOGY (2008)
Medical progress depends on animal models - doesn't it?
Robert A. J. Matthews
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2008)
Cancer surgery: risks and opportunities
JC Coffey et al.
BIOESSAYS (2006)
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy
DC Drummond et al.
CANCER RESEARCH (2006)
Preparation of liposomes using an improved supercritical reverse phase evaporation method
K Otake et al.
LANGMUIR (2006)
Biomolecular modeling: Goals, problems, perspectives
Wilfred F. van Gunsteren et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment
MS Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation
K Ulbrich et al.
JOURNAL OF DRUG TARGETING (2004)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
